Cargando…
Barriers and Opportunities for Use of Patient Registries in Medicines Regulation
Autores principales: | Olmo, Carla Alonso, McGettigan, Patricia, Kurz, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617975/ https://www.ncbi.nlm.nih.gov/pubmed/30970160 http://dx.doi.org/10.1002/cpt.1414 |
Ejemplares similares
-
Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments
por: McGettigan, Patricia, et al.
Publicado: (2019) -
Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation
por: Pacurariu, Alexandra, et al.
Publicado: (2018) -
Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries
por: McGettigan, Patricia, et al.
Publicado: (2013) -
EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making
por: Plueschke, Kelly, et al.
Publicado: (2018) -
Correction to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case–Control Study
por: Morales, Daniel R, et al.
Publicado: (2019)